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Summary All cases of childhood cancer diagnosed before the 15th birthday in the years 1968-1982 and
resident in the Northern Health Authority region have been registered. There were 1171 registrations and only
two have been completely lost to follow up. The overall annual incidence of cancer was 107.1 per million
children, similar to previously reported figures. There was no significant change in the rate over the 15 year
period either for all cancers or individual cancer types. Eighty six percent of registrations had central review
of pathological material. There has been a significant move towards centralisation of care over the 15 years
and a significant improvement in survival over the three quinquennia for all cases and for most individual
types. High white blood cell count at presentation was confirmed as a bad prognostic feature in children with
acute lymphoblastic leukaemia (ALL). Children treated for ALL in a peripheral hospital had a significantly
worse survival than those referred to a specialist centre. Survival rates were calculated for all of the major
types of malignancy. The registry includes four sibling pairs with cancer and one family with three siblings
affected. Ten children developed secondary primary tumours.
Cancer in children is rare with only about 1200 new cases in
England each year. The first requirement for planning and
evaluation of care is the accurate and comprehensive
ascertainment of all patients. The prototype children's cancer
registry was established in Manchester in 1954 and for many
years was the only source of reliable data on the incidence
of malignant disease in childhood (Birch et al., 1980; Leck
et al., 1976). In 1968 the Newcastle Regional (after
reorganisation in 1974, the Northern Regional) Registry was
established along similar lines and this is a report of its first
fifteen years of data collection.
Methods
In late 1967 all Consultants in the old Newcastle Region
were asked to notify to the Secretary of the Malignant
Disease Co-ordinating Committee all children under their
care who were diagnosed as having cancer before their
fifteenth birthday. All cases of malignant disease, benign
intracranial and intraspinal neoplasms and some neoplasms
of uncertain behaviour e.g. Histiocytosis X have been
included. Children had to be less than fifteen years of age
and resident in the region at the time of diagnosis to be
registered. This direct notification has continued and has
been aided by the preparation and circulation of annual
reports for the first 6 years and a larger report at 10 years.
In order to ensure as complete ascertainment of cases as
possible cross checks are undertaken with the Regional
Cancer Registry and with Hospital Activity Analysis returns.
Data collection started on 1 January 1968, and is continuing.
In 1974 the area covered by the Northern Region changed
slightly with the loss of part of North Yorkshire including
Northallerton and the gain of part of South West Cumbria
including Barrow-in-Furness. The population of the Region
remained virtually unchanged following this re-organisation
and the child population under 15 years of the new region in
1975 was 744,000. The Northern Region consists of the area
of Northern England from the Scottish border in the North
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to Cleveland in the south and east, and the whole of Cumbria
in the south and west. Some 2.5 million of the population
live in two large conurbations centred on the rivers Tyne and
Wear including the towns of Newcastle and Sunderland, and
the Tees with the major towns of Middlesbrough and
Stockton. The remainder of the region is largely rural with a
very sparsely scattered population. Registration data include
details of the child and diagnosis along with relevant clinical
details. The pathology for most of the patients treated
outside Newcastle was reviewed centrally by pathologists in
Newcastle. Pathological material is available for 86% of
cases in the registry. The percentage varied according to
disease type - leukaemia 81.6%, brain 74.2%, kidney 98.5%,
bone 96.7%, lymphoma 98.2%. Incidence rates were
calculated using the OPCS mid-year population estimates
(OPCS, 1985). Follow-up information is available for almost
all children and only two were completely lost to follow-up.
Survival curves were obtained using Kaplan Meier methods
and the significance of difference between survival curves
was assessed using the Mantel-Cox (Log Rank) Test
(BMDP Statistical Software Manual, 1983). The chi-square
test with Yates' correction for small numbers was used for
tests of independence. Analysis was carried out taking into
account certain prognostic factors for different diseases. The
difference in outcome between children treated in a 'central'
hospital i.e. one of the Newcastle Hospitals or a 'peripheral'
hospital i.e. any hospital elsewhere in the region was also
considered. There are two neurosurgical units within the
region, one in Newcastle and the other in Middlesbrough.
Patients from South West Cumbria have traditionally been
treated in the Paediatric Oncology Unit in Manchester and
for the purpose of the central vs. peripheral analysis these
children are included in the 'central' group.
Background
A total of 1171 children have been registered. There were
659 boys and 512 girls. Boys predominated in most of the
major groups of tumours except for retinoblastoma where
the ratio was 0.7:1. The yearly registrations according to
diagnosis is shown in Table I, and the average annual
incidence per million child population is shown in Table II
for five successive three year periods with the comparable
figures from the Manchester Children's Tumour Registry
(MCTR) (Birch et al., 1980) and the Greater Delaware
Valley Pediatric Tumor Registry (GDVPTR) (Kramer et al.,
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Table I Annual incidence of malignant disease in the Northern Region 1968-82
X~~~~~~~~~
Year C4 . iC
68 22 3 14 3 4 4 2 3 2 1 1 0 11 70
69 20 5 10 8 3 8 4 1 6 3 3 2 5 78
70 22 4 12 5 7 1 4 5 2 3 0 1 4 70
71 25 7 21 5 5 3 8 3 2 3 2 4 6 94
72 16 5 19 3 5 10 3 1 10 2 5 0 5 84
73 23 4 24 7 6 3 2 5 6 5 2 2 7 96
74 18 4 20 2 6 4 5 4 4 1 0 0 5 73
75 21 4 22 4 3 7 6 3 3 4 0 0 5 82
76 24 5 22 4 3 2 8 2 0 3 2 0 6 81
77 24 5 20 2 6 4 3 6 2 5 3 4 4 88
78 22 5 25 5 3 0 5 3 0 2 0 2 6 78
79 13 4 23 2 6 5 2 5 4 5 3 4 3 79
80 13 2 22 3 2 7 4 0 2 3 0 1 3 62
81 18 3 13 4 3 1 5 2 1 1 4 4 7 66
82 25 7 12 5 3 2 2 4 0 3 2 0 5 70
Total 306 67 279 62 65 61 63 47 44 44 27 24 82 1171
Table II Incidence ofmalignant disease per million children < 15 years per year in 5, 3 year periods.
W~~~~~~~-~ 'g 0E i e; E i apE C,j C.~~
.
~~~~ ~~ ~~~ ~ ~ ~ 0
68-70
71-73
74-76
77-79
80-82
Mean
26.5
27.5
28.3
28.4
29.2
28.0
Manchestera 26.1
GDVPTR(W)b 30.9
GDVPTR(NW)b 15.2
5.0
6.9
5.8
6.8
6.3
6.2
7.0
8.6
7.0
14.9
27.5
28.7
33.0
24.3
25.7
6.6
6.4
4.5
4.4
6.3
5.6
22.5 6.5
27.3 8.8
26.1 4.7
5.8
6.9
5.4
7.3
4.2
5.9
5.4
6.9
5.8
4.4
5.1
5.5
5.1 4.6
6.3 6.1
11.9 6.1
4.2
5.6
8.5
4.8
5.7
5.8
4.5
6.0
4.2
3.7
3.9
4.0
6.8
3.2
4.3
3.6
6.6
6.4
4.1
7.7
3.1
2.9
1.5
3.9
3.0
3.9
5.3
2.9
4.3
3.6
5.8
3.6
4.0
3.9
4.4
4.4
1.7
3.9
0.9
2.9
3.1
2.5
2.6
0.4
0.6
1.2
2.6
0
4.8
2.6
2.3
2.2
2.0
2.8
8.2
7.7
7.2
6.3
7.8
7.4
8.5
8.5
9.7
90.2
117.8
105.8
118.6
102.9
107.1
100.1
119.8
104.4
aManchester figures; bGreater Delaware
(N )
Valley Pediatric Tumor Registry for White (W) and Non-white
1983). There has been a significant move towards
centralisation of care over the three quinquennia, the
proportions treated centrally in the three periods being
59.8%, 73.1% and 82.8% (P<0.001).
There has also been a significant improvement in survival
rates over the three time periods, i.e. 29.8%, 42.9% and
55.2% (P<0.0001).
Leukaemia
a) Acute lymphoblastic leukaemia (ALL)
Acute undifferentiated leukaemia (AUL), a diagnosis more
commonly made in the early years of the Registry, was
included with ALL. Three hundred and six children, 172
boys and 134 girls were registered. There has been a
significant improvement in survival between each successive
quinquennium, Figure 1 (P<0.001). The best survival was
seen in children from 1-9 years, the difference between these
and the older or younger patients being significant
(P<0.001). The white blood cell (WBC) count at diagnosis
was also a significant prognostic factor (P<0.0001). There
was little difference in survival for those with a WBC
from 20-50 x 10'91 or 50-100 x 1091, but those with WBC
<20 x109 1 had a significantly better outcome than those
with > 100 x 109 1. Sex was not a significant prognostic
factor (P=0.2). A significant difference in survival was
observed for those patients in a central vs. peripheral
hospital (P<0.0001). This difference was apparent for all
three quinquennia and is therefore not due to increasing
centralisation of care - Figure 2. The prognostic factors of
age and WBC were similar in the central and peripheral
groups i.e. 77% were aged 1-9 years in the central and 70%
in the peripheral group (P=0.26). There was no significant
difference in the proportion of patients with WBC in the
high, medium and low categories in the central and
peripheral hospital groups. There has been no significant
change in the distributions of WBC at presentation over the
three quinquennia.
b) Acute myeloid leukaemia (AML)
Sixty-seven children with AML have been registered. The
overall survival for patients for the whole of the fifteen years
is 6% and there has been no significant change in outcome
over the three five year periods (P=0.3). Neither sex, age,
WBC or hospital of treatment had any effect on survival.
c) Other leukaemia
There were 4 children with chronic myeloid leukaemia and
one each of erythroleukaemia, malignant myelofibrosis and
granulocytic sarcoma. Only the last patient is surviving 6
years after diagnosis.THE NORTHERN CHILDREN'S MALIGNANT DISEASE REGISTRY 855
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Figure 1 Acute lymphoblastic leukaemia;
B= 1973-1977; C= 1978-1982.
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Figure 2 Acute lymphoblastic leukaemia; A=Central treatment;
B =Peripheral treatment.
CNS tumours
Two hundred and seventy-nine children, 152 boys and 127
girls, were diagnosed as having a CNS tumour during the 15
years.
a) Astrocytoma
Eighty-one children had an astrocytoma, 41 being supra-
tentorial and 40 arising below the tentorium in the
cerebellum. The survival for the supratentorial tumours is
44% and has not changed significantly over the 15 years
(P=0.86). Age, sex and hospital of treatment had no effect
on survival. There has been an improvement in survival for
the patients with cerebellar astrocytoma (P=0.04), Figure 3
shows two periods of seven and eight years. The number of
deaths has decreased significantly during the three five year
periods, i.e. 40%, 12% and 0% (P=0.03). Eight of the
patients with cerebellar astrocytoma were treated in a
peripheral hospital and their survival was not significantly
different from the 31 treated in Newcastle (P=0.32)
although overall there was a lower proportion of deaths
amongst centrally treated patients (0.13 vs. 0.25). Age and
sex had no effect on survival.
b) Medulloblastoma
Fifty-five children, 35 boys and 20 girls, were registered.
Long term survival was 27% and there has been no
significant change over the 15 years. All deaths occurred
within the first five years following diagnosis. Age, sex and
place of treatment had no effect on survival.
-I II III 111|8811 " "I B (N=22)
a l "''A (N=18)
0 2 4 6 8 10 12 14 16 18
Time survived (in years)
Figure 3 Cerebellar astrocytoma; A= 1968-1974; B= 1975-1982.
c) Ependymoma
Twenty-seven children, 17 boys and 10 girls are included.
Long term survival was 24% and although most of the
deaths occurred during the first four years after diagnosis,
one child relapsed and died after seven and a half years.
Age, sex and place of treatment did not affect survival which
did not improve over the fifteen years.
d) Brainstem glioma
The 30 children with brainstem glioma, 10 boys and 20 girls,
had the poorest survival of any group of brain tumour. Only
13% were longterm survivors and all deaths occurred in the
first two years after diagnosis. Again age, sex and place of
treatment were irrelevant to survival.
e) Craniopharyngioma
Of the 20 children, 11 boys and 9 girls, 65% are long term
survivors. Of those children who died, most did so soon
after diagnosis with 5 of the 7 deaths (71%) occurring in the
first six months after diagnosis. Only one patient died after
three years. There was no significant improvement in
survival over time although 73% of the patients diagnosed
from 1975-82 survived compared to 56% for 1968-74. Age,
sex and place of treatment did not affect survival.
f) Pineal tumours
There were 16 children, 8 boys and 8 girls with tumours in
the pineal region and all but two were treated in a central
hospital. Only three were diagnosed before 1975. There has
been a considerable improvement in survival from the first
period of 1968-1977 when it was 25%, to 75% for 1978-
1982 (P=0.062). Age and sex had no effect on survival and
all deaths occurred within two years.
g) Other CNS tumours
A total of 50 children, 23 boys and 27 girls, had a CNS
tumour which could not be fitted into one of the above
categories. Many were gliomas, or were presumed to be so as
they were not accessible to biopsy and included optic nerve
gliomas and oligodendrogliomas. There has been a trend,
although not significant, for more patients to be treated in a
central hospital with time i.e. 67% for the first 7 years and
86% for the last 8 years (P=0.1). Although there has been
no significant improvement in overall survival (P=0.56), the
proportion of deaths has decreased i.e. 0.71, 0.31 and 0.24
for the three five year periods (P=0.02).
Neuroblastoma
Sixty-two children, 33 boys and 29 girls, had neuroblastoma
_856 A.W. CRAFT et al.
and a further three, 1 boy and 2 girls, had a diagnosis of
ganglioneuroblastoma. The stage of tumour according to the
Evans classification (Evans et al., 1971) was I-5, II-1, III-
19, IV-33, IVs-3 and there were 4 cases in the early years of
the registry where stage was not known. The overall
outcome for all patients with neuroblastoma improved in the
1978-82 period when compared to the previous two 5 year
periods (P=0.078) although this result is complicated by a
higher proportion of Stage I-III cases in the first 10 years.
There is only one survivor of Stage IV disease and he was a
boy less than one year old at diagnosis. The survival for
each stage was 1-100%, 11-0%, III-21%, IV-3% and IVs-
100%. Survival was also dependent on age at diagnosis, i.e.
<1 year 35%, 1-4 years 16%, 5+ 5.9% (P=0.06).
Wilms tumour
Sixty-five children, 31 boys and 34 girls had a Wilms tumour
diagnosed. The survival according to stage is shown in
Figure 4 where there is a highly significant difference
(P<0.0001). Survival improved from the first quinquennium
when it was 50% to 67% and 69% in the second and third
periods but this change did not reach significance (P=0.31).
Age and sex did not influence survival. Only two Stage I
patients died. One had had the bone metastasizing variant of
Wilms tumour as described by Marsden and Lawler (1980)
and the other subsequently developed a tumour in the other
kidney i.e. was probably an asynchronous bilateral tumour
and therefore could be classified as stage V although there
were 3 years between the onset of tumour in each of the
kidneys. The distribution of stage of disease has changed
significantly over the 15 years with generally more early
stage disease being diagnosed in the later years (P=0.01).
All of the deaths occurred within two years, apart from one
Stage I patient at 6 years and 2 months and one Stage IV
patient at 3 years and 10 months.
Bone tumours
Osteosarcoma
Thirty-eight children, 19 boys and 19 girls, with osteo-
sarcoma were registered in the fifteen year period. Twenty-
nine of these have died. There was a trend to fewer
registrations with time i.e. 18, 12 and 8 over the three 5 year
periods. The long term survival for those diagnosed from
1968-1974 was 18% and from 1975-82, 31%. This
improvement is not statistically significant (P=0.38). Age,
sex and hospital of treatment had no effect on survival.
Those who had no metastases at diagnosis had a
significantly better chance of survival (P<0.0001) although
this is based on small numbers.
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Ewing's sarcoma
Fifteen boys and three girls, a total of 18, were registered,
with only 4 survivors. The long term survival is 22% and
there was no significant improvement with time (P=0.7).
However, there was a significant difference in survival for
those who did and did not have metastases at the time of
diagnosis (P=0.04). All of those with metastases at diagnosis
(n=6) were dead by three and a half years whereas the long
term survival for those without was 32% at 10 years. Age
had no effect on survival. All 3 girls had metastases at
diagnosis, compared with only 20% ofmales (P=0.03).
Other bone tumours
Two children with osteoclastoma have been registered and
both survive. One case of each of chondrosarcoma,
malignant fibrous histiocytoma and malignant lymphangio-
matosis have all died of the disease.
Non-Hodgkin's lymphoma
Sixty-three children, 47 boys and 16 girls, have been
diagnosed during the 15 years. There has been improvement
in survival over the fifteen years with the three quinquennial
survival rates being 19, 23 and 39%. The difference between
the first 10 and last 5 year periods almost reaches
significance (P=0.06). The survival for those with stage IV
disease was only 17% whereas for the other three stages it
was 31% (P=0.02). Age and sex had no effect on survival.
There was no difference in survival for the whole group
according to hospital of treatment (P=0.2) but this may
have been due to a significantly higher proportion of stage
III and IV cases being treated in the central as opposed to
peripheral hospitals (P=0.04).
Hodgkin's disease
Thirty-nine boys and eight girls were registered, a total of
47. Ten of these have died, nine in the first seven years of
the registry. The improvement in survival for two time
periods is shown in Figure 5. The difference is significant
(P=0.007). Stage and place of treatment had no effect on
survival but those of ten years and under had an improved
chance of survival (P=0.007). Nine of the deaths occurred in
the first 4 years after diagnosis but there was one late death
at 11 years.
Retinoblastoma
Only 4 of the 44 children registered have died. There were 18
boys and 26 girls. Thirty-three were unilateral and 11
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Figure 4 Wilms' tumour; A =Stage I; B =Stage II; C=Stage
III; D=Stage IV; E=Stage V.
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Figure 5 Hodgkin's disease; A= 1968-1974; B= 1975-1982.
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bilateral. There has been a steady decline in the number of
registered cases over the three 5 year periods, i.e. 22, 15 and
7. Four had a known family history of retinoblastoma. Two
of these were first cousins.
Rhabdomyosarcoma
Forty-four children, 29 boys and 15 girls were registered and
34 have died. There has been a significant improvement in
survival for the second 8 years compared to the first 7, i.e.
35% vs. 6% (P=0.007). All deaths occurred within the first
51 months after diagnosis and all but 4 of the patients were
treated centrally.
in 1966 before the registry commenced. These were cerebellar
astrocytoma/retinoblastoma, ALL/medulloblastoma, ALL/
retinoblastoma, retinoblastoma and osteosarcoma/
retinoblastoma and osteosarcoma and adrenocortical
carcinoma/rhabdomyosarcoma/medulloblastoma.
Secondary primary tumours
One girl is included in the registry with an osteosarcoma
who had previously had bilateral retinoblastoma diagnosed
in 1966. A further 10 children in the registry have
subsequently developed a second primary tumour. One child
had four separate primary tumours and details have been
given previously (Pearson et al., 1983).
Soft tissue sarcoma
Seven children with fibrosarcoma, two with neurofibro-
sarcoma, two with synovial sarcoma and nine other soft
tissue sarcomas were registered. Eleven of these 18 have died
and there has been no significant improvement in survival
(P=0.3).
Yolk sac tumours
Twenty-four children, 16 boys and 8 girls, were registered.
Twenty one were aged 9 years or less. Seven have died, six
during the first ten years from 1968-1977. Only one death
has occurred in the latter period from 1978-82. Although
there does appear to be an improvement in survival, 91% in
1978-82 vs. 54% in 1968-77, this does not reach significance
because of the small numbers involved (P=0.13). Fourteen
involved the testis, 5 the ovary and the remaining 5 other
sites in the body.
Hepatoblastoma and hepatocarcinoma
Of the 8 children registered 2 boys and 6 girls, 7 were less
than 10 years of age. Six have died and 5 of these were prior
to 1977. Six had hepatoblastoma and 2 hepatocarcinoma.
Histiocytosis X
Three of the 27 cases of histiocytosis X have died. All three
were under 2.5 years of age and were diagnosed in the first
ten years of the registry. There has been a significant trend
towards centralisation of care (P=0.01).
Thyroid tumours
There were six children registered with thyroid tumours.
Three were carcinomas, two medullary carcinomas and one
papillary carcinoma. All were diagnosed before 1978 and
none has died.
Miscellaneous
Thirty-eight other children were registered with a wide
variety of uncommon malignant tumours. Seventeen of these
have died.
Familial cases
The registry contains 4 sibling pairs and one family where 3
siblings had cancer although one of the latter was diagnosed
Discussion
The ideal features of a children's cancer registry are that it
should cover a defined geographical area and have ascertain-
ment of cases as complete as possible. The Manchester
Children's Tumour Registry (MCTR) was established in
1954 with the aim of achieving these two goals (Birch et al.,
1980). The Northern Region Registry was set up in 1968
using the MCTR as a model. Since then the Greater
Delaware Valley Pediatric Tumour Registry (GDVPTR)
based in Philadelphia, USA, was started in 1970 and a
report of the registration for the first decade was produced
in 1983 (Kramer et al., 1983).
Table II shows the annual incidence for the Northern
Region Registry with comparable figures for the MCTR and
the GDVPTR for both white and non-white children. The
annual incidence of 107.1 per million children is remarkably
similar to that of the MCTR although somewhat less than
for whites in the Philadelphia series but almost identical to
that for non-whites in the latter registry. There is an
increasing non-white population in the UK but for the
period covered by the MCTR the local population was
predominantly white and the Northern Region remains so.
The remarkably similar figures for the Northern Region and
the MCTR suggest that by utilising the same methods the
ascertainment- in the Northern Region is equally
comprehensive. For the MCTR it has been estimated to be
98% complete (Leck et al., 1984) and it is therefore likely
that this is so for the Northern Region.
The next requisite of a Registry after ensuring complete
ascertainment is that there should be central reviews of
pathological material by pathologists experienced in the
diagnosis and classification of children's tumours. Material
from 94% of the solid tumours in the MCTR and 85% of
the Philadelphia cases was reviewed. Overall 86% of the
cases in the present series had a central review and for some
categories e.g. kidney (98.5%) and lymphoma (98.4%) it was
much higher. The Northern Region Children's Cancer
Registry therefore appears to be of at least a similar
standard as the two previously reported registries. With only
two cases completely lost to follow-up there is an almost
unique opportunity for complete collection of follow up
data. This reflects the relatively static nature of the
population of the region.
The pattern of disease in the two English registries is
remarkably similar suggesting that large geographic
variations in childhood cancer do not exist, at least in two
contiguous areas in the same country. However, more
striking differences do occur in the US data both within
their own population for white and non-white subjects and
also between the US and English data. Many of the
individual types of childhood cancer seem to be slightly more
common in US white children and the overall annual
incidence at 120 per million children is considerably higher
than the 107 or 100 in the English registries.858 A.W. CRAFT et al.
Within the Northern Region data there are no significant
changes in incidence of childhood cancer with time although
the relatively short time period and small numbers of cases
may have obscured any such change. The only exception to
this appears to be a low incidence of CNS tumours in the
first three year period as shown in Table II. Ascertainment
procedures were identical for the whole fifteen year period,
but the isolated occurrence of an apparent deficit in the first
period for a single disease category suggests that there may
have been some under-recording at this time. The incidence
of leukaemia has been remarkably constant. The MCTR
reported a significant increase during the period 1954-77
(Birch et al., 1979,1981). The excess was mainly in young
boys below the age of four. The Northern Region data do
not show any such trend and this is in accord with the recent
report from the Netherlands (van Steenson-Moll et al., 1983)
on leukaemia incidence from 1973-1980. The increase in
incidence in the MCTR data was based on both a cusum
and a regression method of analysis using the first ten years
from 1954-64 as a baseline. No other registry has these early
data. Examination of the MCTR without the cusum
technique would not show an increase. A significant rise
reported from the whole of Great Britain from 1968-78 may
have been shown because of the much larger volume of data
available (Stiller & Draper, 1982).
Registry data can also be used to look at patterns of
disease within a region and this was particularly helpful
when giving accurate information to the enquiry by Sir
Douglas Black into an alleged excess of cancer in young
people around the Sellafield nuclear fuel reprocessing plant
(Black, 1984) and subsequently the geographical distribution
of cancer in children in the Northern Region has been
reported in more detail (Craft et al., 1985).
Data collected over a prolonged period provide the
opportunity to study changes in survival and any specific
factors associated with improvements. For some of the larger
individual disease groups in the Northern Region it has been
possible to show an improvement in survival over the 15
year period. The prognosis for patients with acute lympho-
blastic leukaemia has improved significantly with time. Other
important prognostic factors were the white blood cell count
at presentation, confirming this well recognised feature and
perhaps more importantly, the centralisation of care into a
hospital which can concentrate expertise in the management
of a rare disease. Those treated centrally and peripherally in
the present series would seem to be comparable in terms of
other prognostic factors and the significantly better survival
in those treated centrally argues strongly for centralisation.
Similar figures are soon to be reported on a national basis
for Great Britain (Stiller C, Personal Communication).
Many of the other disease categories do show considerable,
and in many cases, significant improvements in survival over
the period of 15 years. It is during this time that the
specialty of paediatric oncology and the concept of a
paediatric oncology team consisting of oncologist, radio-
therapist, surgeon, haematologist and pathologist has
developed. A rational basis for the use of the three
modalities of treatment, surgery, radiotherapy and chemo-
therapy has evolved and the benefits are clearly shown by
the improvements in survival. However, there are some
exceptions to this: acute myeloid leukaemia, advanced neuro-
blastoma and some of the brain tumours have shown little
improvement over the 15 year period.
The concept of treating rare cancers in specialist centres
has been advocated both for children and adults (Stiller
1987; Editorial, 1986). The MCTR showed a benefit for such
centralisation during the years 1954-68 (Marsden & Steward,
1976). Reports from the GDVPTR in the US on a regional
basis (Kramer et al., 1984) and on a national basis in Great
Britain by the Childhood Cancer Research Group in Oxford
(Stiller, 1987) have shown clear benefits from such
centralisation of care for both leukaemia and solid tumours.
The survival rates reported here are those actually
observed in a whole population over a 15 year period during
which time there have been continuing advances in our
understanding and management of the problems of
childhood cancer. They do not represent the optimum
survival which could have been achieved either during this
period or which should now be possible. Most reported
series of survival in childhood cancer represent selected
groups of patients and it is only when the optimum
treatment can be given to all children within a defined area
that we can be truly satisfied.
We are indebted to all of the consultant staff throughout the
Northern Regioi who have ensured the success of the registry. We
are also grateful to the DHSS, Newcastle Students Rag Committee,
Tyneside Leukaemia Research Association, the North of England
Cancer Research Campaign, and the North of England Children's
Cancer Research Fund for financial support of the Registry. Mrs
Pat Bagnall, Mrs Elaine Boston, Miss Shirley Brailsford, Mrs
Marillyn Stewart and Mrs Lorna More have been secretaries to the
Registry.
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